According to Zhitong Finance App News, Merry Health International (02327.HK) announced that on September 21, 2026 (after the trading period), the company signed an agreement with the seller Yucheng Industrial Co., Ltd., according to which, the seller has agreed to sell, and the company has agreed to acquire sales shares (equivalent to the entire issued share capital of the target company Dexin Pharmaceutical Development Co., Ltd.) through the buyer Meirui Group Development Co., Ltd. (a wholly-owned subsidiary of the company), at a total cost of HK$35.2 million.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.